Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Filamon LTD
AstraZeneca
Tomsk National Research Medical Center of the Russian Academy of Sciences
Kivu Bioscience Inc.
NeoImmuneTech
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
Hoffmann-La Roche
Rutgers, The State University of New Jersey
National Institutes of Health Clinical Center (CC)
Bayer
Psyence Australia Pty Ltd
ViroMissile, Inc.
University of California, Davis
Gustave Roussy, Cancer Campus, Grand Paris
Dana-Farber Cancer Institute
Jazz Pharmaceuticals
Centre Antoine Lacassagne
Duke University
AstraZeneca
Essen Biotech
MBrace Therapeutics
Eli Lilly and Company
Angiex, Inc.
Poseida Therapeutics, Inc.
MacroGenics
Poitiers University Hospital
Unity Health Toronto
General Oncology, Inc.
City of Hope Medical Center
Daiichi Sankyo
SN BioScience
Takeda
Eli Lilly and Company
HealthPartners Institute
National Institutes of Health Clinical Center (CC)
Second Life Therapeutics
Eli Lilly and Company
University of Washington
Var2 Pharmaceuticals
MOMA Therapeutics
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Mayo Clinic
City of Hope Medical Center
Abramson Cancer Center at Penn Medicine
Merck Sharp & Dohme LLC
City of Hope Medical Center